HUTCHMED (China) (HMDCF) Cash & Current Investments (2014 - 2025)
HUTCHMED (China) (HMDCF) reported Cash & Current Investments of $1.5 billion for Q4 2025, up 1268.43% year-over-year from $107.5 million in Q4 2024, and up 7.86% quarter-over-quarter from $1.4 billion in Q2 2025.
HUTCHMED (China) (HMDCF) Cash & Current Investments (2014 - 2025) Analysis & Trends
HUTCHMED (China) (HMDCF) has 12 years of Cash & Current Investments data on file, last reported at $1.5 billion in Q4 2025.
- Cash & Current Investments for Q4 2025 came in at $1.5 billion, up 1268.43% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.5 billion (up 1268.43% YoY), and the FY2025 annual result was $175.8 million, down 38.01% from the prior year.
- Cash & Current Investments climbed to $1.5 billion in Q4 2025 per HMDCF's latest filing, from $1.4 billion in the prior quarter.
- Over five years, Cash & Current Investments peaked at $1.5 billion in Q4 2025 and troughed at $113433.7 in Q4 2023.
- A 5-year average of $537.6 million and a median of $285.6 million in 2021 frame the typical range for Cash & Current Investments.
- The sharpest annual moves came in 2023 and 2024: Cash & Current Investments tumbled 99.86% in 2023, then jumped 94712.72% in 2024.
- A 5-year view of Cash & Current Investments shows it stood at $129.9 million in 2021, then tumbled by 37.89% to $80.7 million in 2022, then tumbled by 99.86% to $113433.7 in 2023, then jumped by 94712.72% to $107.5 million in 2024, then surged by 1268.43% to $1.5 billion in 2025.
- Business Quant data shows HMDCF's Cash & Current Investments at $1.5 billion in Q4 2025, $1.4 billion in Q2 2025, and $107.5 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 3.74 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.94 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 2.15 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 77.77 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.32 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 428.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 511.86 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 750.88 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 498.58 Mn |
| 10 | HUTCHMED (China) | - | - | - | 1.47 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.47 Bn |
| Jun 30, 2025 | 1.36 Bn |
| Dec 31, 2024 | 107.55 Mn |
| Jun 30, 2024 | 102.65 Mn |
| Dec 31, 2023 | 113,433.74 |
| Jun 30, 2023 | 946.45 Mn |
| Dec 31, 2022 | 80.67 Mn |
| Jun 30, 2022 | 826.20 Mn |
| Dec 31, 2021 | 129.88 Mn |
| Jun 30, 2021 | 598.64 Mn |
| Mar 31, 2021 | 285.57 Mn |
| Dec 31, 2020 | 320.70 Mn |
| Jun 30, 2020 | 352.23 Mn |
| Mar 31, 2020 | 121.16 Mn |
| Dec 31, 2019 | 182.05 Mn |
| Sep 30, 2019 | 190.53 Mn |
| Jun 30, 2019 | 237.29 Mn |
| Mar 31, 2019 | 266.21 Mn |
| Dec 31, 2018 | 300.18 Mn |
| Sep 30, 2018 | 85.27 Mn |